Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.

Siegel CA., Melmed GY., McGovern DP., Rai V., Krammer F., Rubin DT., Abreu MT., Dubinsky MC., International Organization for the Study of Inflammatory Bowel Disease (IOIBD) None., International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) None.

Original publication

DOI

10.1136/gutjnl-2020-324000

Type

Journal article

Journal

Gut

Publication Date

04/2021

Volume

70

Pages

635 - 640

Addresses

Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA corey.a.siegel@hitchcock.org.

Keywords

International Organization for the Study of Inflammatory Bowel Disease (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD), Humans, Inflammatory Bowel Diseases, Anti-Inflammatory Agents, Vaccination, Consensus, Gastroenterology, International Cooperation, Immunomodulation, Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines